Apricus Biosciences (APRI) Refocuses Strategy on Vitaros, Femprox; Updates on Outlook
Tweet Send to a Friend
Apricus Biosciences, Inc. (Nasdaq: APRI) provided an update regarding ongoing corporate activities and announced that its Annual Report on Form ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE


